Literature DB >> 8285737

The use of Food and Drug Administration--approved medications for unlabeled (off-label) uses. The legal and ethical implications.

A Torres1.   

Abstract

Physicians increasingly use Food and Drug Administration (FDA)-approved drugs (medication) for unlabeled (off-label) indications. The ethical and legal implications of these actions are not always clear. In this article, I examine the common law and federal statutory regulations concerning this issue and also explore some of the ethical and financial issues involved.

Keywords:  Food, Drug, and Cosmetic Act; Legal Approach; Professional Patient Relationship

Mesh:

Substances:

Year:  1994        PMID: 8285737

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  2 in total

Review 1.  The introduction of new drugs into anaesthetic practice: a perspective in pharmaceutical development and regulation.

Authors:  I Gilron
Journal:  Can J Anaesth       Date:  1995-06       Impact factor: 5.063

2.  Informed consent and shared decision-making: a requirement to disclose to patients off-label prescriptions.

Authors:  Michael Wilkes; Margaret Johns
Journal:  PLoS Med       Date:  2008-11-11       Impact factor: 11.069

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.